Small interfering RNA (siRNA) Therapeutics - Competitive Landscape, Technology and Pipeline Insights, 2016; New Report Launched

The Report, “Small interfering RNA (siRNA) Therapeutics- Competitive Landscape, Technology and Pipeline Insights, 2016” depicts the current pipeline scenario of siRNA therapies under development. Many targets which were difficult to reach by traditional small-molecule and protein have been identified by therapeutics based on RNA interference (RNAi). RNA interference (RNAi), a process in recovery Phase, is still keeping the expectations of the many mid Pharma companies at a higher end with blockbuster deals and adequate delivery technologies.

This report analysis the current frontrunners in siRNA therapies with leading technologies and major acquisitions and deals seen in past 3 years. Report highlights the 16 different types of technologies that have been used lately to enhance the siRNA development in different stages of development.

There are 15+ active companies dealing with 85+ siRNA therapies. Mostly siRNA is being studied for oncology area with 27 siRNA therapies under development by major pharma companies followed by 14 therapies for infectious diseases and 8 siRNA therapies in Ophthalmology. Currently 23 siRNA are in clinical stage of development with many mid-stage products.

Scope:

• Coverage of global siRNA therapies under development across the globe
• Competitive landscape of investigational products for key players and key therapy areas
• The new siRNA report includes emerging technologies, drivers, barriers and eminent therapy areas focused by major companies.
• Detailed information on product description and related stage of development, the mode of therapy, mechanism of action, development partner and technology information.
• Report has highlighted the major collaborations, deals and acquisitions done by pharma companies to enrich their siRNA pipeline.
• Report analyzes the different emerging delivery technologies by companies and products under development.

Reason to Buy

• The siRNA report covers complete Pipeline intelligence and understanding over therapeutics development for siRNA.
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Identify and understand important and diverse types of therapeutics under development for siRNA
• The siRNA report helps to develop a better understanding of the emerging technologies by the recent acquisitions which are driving the siRNA market
• Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
• Devise corrective measures for pipeline projects by understanding siRNA pipeline in-depth
• Identifying the upcoming leaders in the siRNA market in the coming year

Spanning over 350 pages, “Small interfering RNA (siRNA) Therapeutics - Competitive Landscape, Technology and Pipeline Insights, 2016” report covers Executive Summary, Introduction, Pipeline Overview, Comparative Analysis, Appendix, Methodology.

For more information Visit at: http://mrr.cm/Joq

Find all Diseases Reports at: http://www.marketresearchreports.com/diseases